COMPANY SEARCH RESULT
Last update : 21/08/2018 >View issuer details
2020.03.27 | 21:01 | Permanent Information Releases / Notification of availability
2020.03.27 | 21:01 | Permanent Information Releases / Notification of availability
2020.03.17 | 21:01 | Permanent Information Releases / Operations
Galapagos increases share capital through warrant exercises - HTML (w)
2020.03.17 | 21:01 | Permanent Information Releases / Operations
Galapagos verhoogt kapitaal door uitoefening van warrants - HTML (w)
2020.02.20 | 22:01 | Permanent Information Releases / Sales and Revenues
2020.02.20 | 22:01 | Permanent Information Releases / Sales and Revenues
2020.01.29 | 08:00 | Permanent Information Releases / General Company News
Orphan Drug Designation for GLPG1690 in systemic sclerosis - HTML (w)
2020.01.29 | 08:00 | Permanent Information Releases / General Company News
GLPG1690 krijgt status van weesgeneesmiddel voor systemische sclerose - HTML (w)
2020.01.23 | 22:01 | Permanent Information Releases / Appointments
Galapagos appoints Michele Manto as Chief Commercial Officer - HTML (w)
2020.01.23 | 22:01 | Permanent Information Releases / Appointments
Galapagos benoemt Michele Manto als Chief Commercial Officer - HTML (w)
2020.01.15 | 07:30 | Permanent Information Releases / General Company News
Fibrocor and Galapagos sign expanded collaboration in fibrosis - HTML (w)
2020.01.15 | 07:30 | Permanent Information Releases / General Company News
Fibrocor en Galapagos breiden samenwerking uit op het gebied van fibrose - HTML (w)
2020.01.13 | 07:30 | Permanent Information Releases / General Company News
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis - HTML (w)
2020.01.13 | 07:30 | Permanent Information Releases / General Company News
2020.01.09 | 22:01 | Permanent Information Releases / General Company News
Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference - HTML (w)
Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 224
